Ian Pavord
Researcher Next ID · RN-031837
Researcher · Medicine
Oxford, United Kingdom
- Works count
- 1,290
- Citation count
- 71,425
- H-index
- 128
- i10-index
- 459
Research interests
Publications
Air pollution and COPD: GOLD 2023 committee report
European Respiratory Journal · 2023 · https://doi.org/10.1183/13993003.02469-2022
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
European Respiratory Journal · 2023 · https://doi.org/10.1183/13993003.00239-2023
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
American Journal of Respiratory and Critical Care Medicine · 2023 · https://doi.org/10.1164/rccm.202301-0106pp
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review
American Journal of Respiratory and Critical Care Medicine · 2022 · https://doi.org/10.1164/rccm.202201-0209pp
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report
European Respiratory Journal · 2019 · https://doi.org/10.1183/13993003.02058-2018
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
European Respiratory Journal · 2019 · https://doi.org/10.1183/13993003.00164-2019
After asthma: redefining airways diseases
The Lancet · 2017 · 10.1016/s0140-6736(17)30879-6
Physiotherapy breathing retraining for asthma: a randomised controlled trial
The Lancet Respiratory Medicine · 2017 · https://doi.org/10.1016/s2213-2600(17)30474-5
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1708208
Treatable traits: toward precision medicine of chronic airway diseases
European Respiratory Journal · 2016 · 10.1183/13993003.01359-2015
Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank
The Lancet Respiratory Medicine · 2015 · https://doi.org/10.1016/s2213-2600(15)00283-0
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
The Lancet Respiratory Medicine · 2015 · https://doi.org/10.1016/s2213-2600(15)00367-7
Current evidence and future research needs for FeNO measurement in respiratory diseases
Respiratory Medicine · 2014 · https://doi.org/10.1016/j.rmed.2014.02.005
Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers
American Journal of Respiratory and Critical Care Medicine · 2011 · https://doi.org/10.1164/rccm.201104-0597oc
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
American Journal of Respiratory and Critical Care Medicine · 2009 · https://doi.org/10.1164/rccm.200801-060st
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0808991
Breathing exercises for asthma: a randomised controlled trial
Thorax · 2008 · https://doi.org/10.1136/thx.2008.100867
Cluster Analysis and Clinical Asthma Phenotypes
American Journal of Respiratory and Critical Care Medicine · 2008 · https://doi.org/10.1164/rccm.200711-1754oc
A new perspective on concepts of asthma severity and control
European Respiratory Journal · 2008 · https://doi.org/10.1183/09031936.00155307
Mast-Cell Infiltration of Airway Smooth Muscle in Asthma
New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa012705
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)11679-5
Current projects
No projects listed.